Safe Orthopaedics announces its revenues for the 1st half of 2020
- Revenues of 1,731 M€ for the first half of 2020, a decline of only 15% despite the impact of the sanitary crisis
- Significant resumption of business on direct distribution markets in June 2020
- Confirmation of the creation of a French leading group for ready-to-use technologies for spinal surgery, submitted to the Annual General Meeting on July 24th, 2020 for approval
Eragny-sur-Oise, France, July 8th, 2020, 17h45 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, today announces its revenues for the first half of 2020.
“Safe Orthopaedics ends the first Semester of 2020 with a global decrease of half-year sales of only 15% compared to the first Semester 2019, despite a decrease in activity on direct distribution of -39% in April and on indirect distribution of -87% in May. The efficiency of our ready-to-use technologies, particularly suitable for emergency surgeries, limited the decrease in sales, despite the exceptional context of the COVID-19 pandemic, and allowed a quick return to business activity in June, following the recovery of surgeries in hospitals that were postponed during the lockdown period. The implementation of governmental measures and the support of ABO were a key to reinforce our cash position and to launch strategical operations” Pierre Dumouchel, CEO and co-founder of Safe Orthopaedics, comments. “This episode of worldwide pandemic strengthens our confidence in our strategy of integrating the entire value creation chain in France, and in our decision to acquire our main supplier LCI Medical. The optimization of the innovation and implantation (time between production and use in operating rooms) cycles will allow this new Safe group to ensure its customers a reactivity and an accrued medico-economical service offering”.
Revenues on June 30th, 2020
|Thousands of euros||Q1 20||Q2 20||S1 2020||Q1 19||Q2 19||S1 2019||
Q2 20/ Q2 19
S1 20/ S1 19
|Direct sales (FR, Ger, UK)||530||353||883||546||458||1 003||-23%||-12%|
|Indirect sales||551||297||848||527||505||1 032||-41%||-18%|
|Total revenue||1 081||650||1 731||1 073||963||2 036||-32%||-15%|
In this context of lockdown, entered into force mid-March and progressively lifted mid-May, the recorded sales during the second quarter for the French team amount to 710k€ versus 853 k€ in 2019, a decrease of only 26%, knowing that the revenues for April were 50% lower compared to the previous year.